Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

The Year Ahead In Europe: More Price Cuts, More Austerity

Executive Summary

Further austerity plans will be drawn up and drug price cuts implemented in Europe during 2012, as governments try to come to grips with their debts and with the eurozone currency crisis.

You may also be interested in...



Italian Rx Price Cuts Are Brand Pharma’s Pain; Will They Even Be Generics’ Gain?

As Italy’s government turns the austerity screw, physicians will need to be convinced to adopt INN-based prescribing in order for sales to see a boost.

European Regulatory Round-Up: EMA And The UK Heed The Calls Of Industry; France Is Otherwise Occupied

The European Medicines Agency follows through on its transparency initiative with comprehensive list of products under review and also reduces pharmacovigilence data reporting requirements.

European Regulatory Round Up: While EMA Opens Up, European Pharma Battens Down For Tough Year

The European Medicines Agency is focusing on transparency and pharmacovigilance over the next year, while the pharmaceutical industry is gearing up for a fight against austerity measures.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

LL1135495

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel